Y-Mabs Therapeutics Inc (YMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | YMAB | ENTA | AGMB | ||
| Company | Y-Mabs Therapeutics Inc | Enanta Pharmaceutica | Agomab Therapeutics NV Adrs | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 8.59 | 13.50 | 10.55 | ||
| High | 8.61 | 13.97 | 11.02 | ||
| Low | 8.59 | 13.40 | 10.55 | ||
| Latest | 8.61 | 13.83 | 10.94 | ||
| Change | +0.02 | +0.22 | +0.24 | ||
| % Change | +0.23% | +1.62% | +2.24% | ||
| Volume | 760,600 | 141,500 | 27,800 | ||
| 20-Day Average Volume | 874,510 | 202,165 | 81,305 | ||
| Previous Close | 8.59 | 13.61 | 10.70 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 8.56 | 14.15 | 11.30 | ||
| 20-Day Raw Stochastic | 100.00% | 32.91% | 22.99% | ||
| 20-Day Relative Strength | 77.65 | 49.21 | 46.37 | ||
| Weighted Alpha | -45.79 | +88.01 | N/A | ||
| Today's Opinion | 88% Buy | 64% Buy | N/A | ||
| Previous Opinion | 88% Buy | 40% Buy | N/A | ||
| Last Month's Opinion | 56% Buy | 40% Buy | N/A | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.23% since 09/08/25 | +0.14% since 05/14/26 | -0.91% since 05/14/26 | ||
| Low | 8.57 on 09/11/25 | 13.19 on 05/15/26 | 10.10 on 05/18/26 | ||
| High | 8.61 on 09/15/25 | 14.24 on 05/20/26 | 11.03 on 05/15/26 | ||
| 1-Month | |||||
| %Chg | +1.06% since 08/15/25 | +4.46% since 04/21/26 | -0.09% since 04/21/26 | ||
| Low | 8.51 on 08/18/25 | 12.80 on 04/24/26 | 10.10 on 05/18/26 | ||
| High | 8.61 on 09/15/25 | 15.93 on 05/07/26 | 13.75 on 05/06/26 | ||
| 3-Month | |||||
| %Chg | +82.80% since 06/13/25 | +2.37% since 02/20/26 | -29.42% since 02/20/26 | ||
| Low | 3.90 on 06/20/25 | 11.75 on 03/30/26 | 9.00 on 04/09/26 | ||
| High | 8.61 on 09/15/25 | 15.93 on 05/07/26 | 17.45 on 03/03/26 | ||
| 6-Month | |||||
| %Chg | +84.37% since 03/14/25 | +8.64% since 11/21/25 | N/A since 02/06/26 | ||
| Low | 3.55 on 05/15/25 | 11.75 on 03/30/26 | 9.00 on 04/09/26 | ||
| High | 8.61 on 09/15/25 | 17.15 on 12/29/25 | 17.45 on 03/03/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 391,221 | 395,751 | 387,736 | ||
| Shares Outstanding, K | 45,438 | 29,078 | 36,237 | ||
| Annual Sales | 87,690,000 | 65,320,000 | 0 | ||
| Annual Net Income | -29,670,000 | -81,890,000 | -62,547,000 | ||
| Last Quarter Sales | 19,530,000 | 17,160,000 | 0 | ||
| Last Quarter Net Income | -3,240,000 | -13,090,000 | -17,401,000 | ||
| 60-Month Beta | 0.53 | 1.01 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.07 on 08/08/25 | -0.45 on 05/11/26 | N/A | ||
| Earnings Date | 11/14/25 | 08/10/26 | 07/23/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||